Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1988 1
1991 7
1992 4
1993 2
1994 1
1996 4
1997 2
1998 5
1999 3
2000 7
2001 8
2002 5
2003 6
2004 6
2005 5
2006 7
2007 1
2008 4
2009 7
2010 10
2011 7
2012 14
2013 7
2014 13
2015 10
2016 11
2017 3
2018 7
2019 9
2020 13
2021 8
2022 6
2023 4
2024 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

193 results

Results by year

Filters applied: . Clear all
Page 1
Risk of HIV transmission through condomless sex in serodifferent gay couples with the HIV-positive partner taking suppressive antiretroviral therapy (PARTNER): final results of a multicentre, prospective, observational study.
Rodger AJ, Cambiano V, Bruun T, Vernazza P, Collins S, Degen O, Corbelli GM, Estrada V, Geretti AM, Beloukas A, Raben D, Coll P, Antinori A, Nwokolo N, Rieger A, Prins JM, Blaxhult A, Weber R, Van Eeden A, Brockmeyer NH, Clarke A, Del Romero Guerrero J, Raffi F, Bogner JR, Wandeler G, Gerstoft J, Gutiérrez F, Brinkman K, Kitchen M, Ostergaard L, Leon A, Ristola M, Jessen H, Stellbrink HJ, Phillips AN, Lundgren J; PARTNER Study Group. Rodger AJ, et al. Lancet. 2019 Jun 15;393(10189):2428-2438. doi: 10.1016/S0140-6736(19)30418-0. Epub 2019 May 2. Lancet. 2019. PMID: 31056293 Free PMC article.
Sexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy.
Rodger AJ, Cambiano V, Bruun T, Vernazza P, Collins S, van Lunzen J, Corbelli GM, Estrada V, Geretti AM, Beloukas A, Asboe D, Viciana P, Gutiérrez F, Clotet B, Pradier C, Gerstoft J, Weber R, Westling K, Wandeler G, Prins JM, Rieger A, Stoeckle M, Kümmerle T, Bini T, Ammassari A, Gilson R, Krznaric I, Ristola M, Zangerle R, Handberg P, Antela A, Allan S, Phillips AN, Lundgren J; PARTNER Study Group. Rodger AJ, et al. Among authors: antela a. JAMA. 2016 Jul 12;316(2):171-81. doi: 10.1001/jama.2016.5148. JAMA. 2016. PMID: 27404185 Free article.
Effectiveness and tolerability of dolutegravir/lamivudine for the treatment of HIV-1 infection in clinical practice.
Suárez-García I, Alejos B, Hernando V, Viñuela L, Vera García M, Rial-Crestelo D, Pérez Elías MJ, Albendín Iglesias H, Peraire J, Tiraboschi J, Díaz A, Moreno S, Jarrín I; Cohort of the Spanish HIV/AIDS Research Network (CoRIS). Suárez-García I, et al. J Antimicrob Chemother. 2023 Jun 1;78(6):1423-1432. doi: 10.1093/jac/dkad102. J Antimicrob Chemother. 2023. PMID: 37099559 Free PMC article.
LipoDDx: a mobile application for identification of rare lipodystrophy syndromes.
Araújo-Vilar D, Fernández-Pombo A, Rodríguez-Carnero G, Martínez-Olmos MÁ, Cantón A, Villar-Taibo R, Hermida-Ameijeiras Á, Santamaría-Nieto A, Díaz-Ortega C, Martínez-Rey C, Antela A, Losada E, Muy-Pérez AE, González-Méndez B, Sánchez-Iglesias S. Araújo-Vilar D, et al. Among authors: antela a. Orphanet J Rare Dis. 2020 Apr 2;15(1):81. doi: 10.1186/s13023-020-01364-1. Orphanet J Rare Dis. 2020. PMID: 32241282 Free PMC article.
Primary prevention.
Antela A, Azcoaga A, Sampedro E, Poveda T. Antela A, et al. Enferm Infecc Microbiol Clin (Engl Ed). 2018 Sep;36 Suppl 1:31-34. doi: 10.1016/S0213-005X(18)30244-1. Enferm Infecc Microbiol Clin (Engl Ed). 2018. PMID: 30115406 English, Spanish.
Redefining therapeutic success in HIV patients: an expert view.
Antela A, Rivero A, Llibre JM, Moreno S; RET Group. Antela A, et al. J Antimicrob Chemother. 2021 Sep 15;76(10):2501-2518. doi: 10.1093/jac/dkab168. J Antimicrob Chemother. 2021. PMID: 34077524 Free PMC article. Review.
Chronicity, ageing and multimorbidity.
Brañas F, Azcoaga A, García Ontiveros M, Antela A. Brañas F, et al. Among authors: antela a. Enferm Infecc Microbiol Clin (Engl Ed). 2018 Sep;36 Suppl 1:15-18. doi: 10.1016/S0213-005X(18)30241-6. Enferm Infecc Microbiol Clin (Engl Ed). 2018. PMID: 30115402 English, Spanish.
The role of tenofovir alafenamide in future HIV management.
Antela A, Aguiar C, Compston J, Hendry BM, Boffito M, Mallon P, Pourcher-Martinez V, Di Perri G. Antela A, et al. HIV Med. 2016 May;17 Suppl 2:4-16. doi: 10.1111/hiv.12401. HIV Med. 2016. PMID: 26952360 Free article. Review.
193 results